SaaS Metrics
Annexon Q2 Earnings Call Highlights
Keyword: Pharmacokinetics
Key Points
Interested in Annexon, Inc.? Here are five stocks we like better.
Annexon expanded the ARCHER II trial of vonaprument in geographic atrophy to include an independent 24-… [+8289 chars]
Read Full Story ↗
Related Content
-
Related Story AC Immune’s anti-inflammatory drug posts early-stage win
-
Related Story BioMarin acquiring Alesta Therapeutics for $275 million